Skip to main content
SpringerLink
Log in

Ocular surface disease in diabetes

  • Chapter
  • First Online:
Managing Diabetic Eye Disease in Clinical Practice

Abstract

Diabetes mellitus is an important cause of numerous ocular disease processes. In addition to well-known conditions such as cataract and diabetic retinopathy (DR), ocular surface diseases are a common cause of discomfort and visual impairment. The number of people over the age of 50 in the United States suffering from dry eye disease is reported to be 3.2 million and 1.6 million, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.

    Google Scholar 

  2. Schaumberg DA, Dana R, Buring JE, et al. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127:763-768.

    Google Scholar 

  3. Hom M, De Land P. Self-reported dry eyes and diabetic history. Optometry. 2006;77:554-558.

    Google Scholar 

  4. Chiang PP, Lamoureux EL, Zheng Y, et al. Frequency and risk factors of no-retinopathy ocular conditions in people with diabetes: the Singapore Malay Eye Study. Diabet Med. 2013;30:e32-e40.

    Google Scholar 

  5. Kaiserman I, Kaiserman N, Nakar S, et al. Dry eye in diabetic patients. Am J Ophthalmol. 2005;139:498-503.

    Google Scholar 

  6. Nepp J, Abela C, Polzer I, et al. Is there a correlation between the severity of diabetic retinopathy and keratoconjunctivitis sicca? Cornea. 2000;19:487-491.

    Google Scholar 

  7. Ozdemir M, Buyukbese MA, Cetinkaya A, et al. Risk factors for ocular surface disorders in patients with diabetes mellitus. Diabetes Res Clin Pract. 2003;59:195-199.

    Google Scholar 

  8. Schultz RO, Van Horn DL, Peters MA, et al. Diabetic keratopathy. Trans Am Ophthalmol Soc. 1981;79:180-199.

    Google Scholar 

  9. Chung J, Tolentino FI, Cajita VN, et al. Reevaluation of corneal complications after closed vitrectomy. Arch Ophthalmol. 1998;106:916-919.

    Google Scholar 

  10. Foulks GN, Thoft RA, Perry HD, et al. Factors related to corneal epithelial complications after closed vitrectomy in diabetics, Arch Ophthalmol. 1997;97:1076-1078.

    Google Scholar 

  11. Alves MD, Carvalheira JB, Modulo CM, et al. Tear film and ocular surface changes in diabetes mellitus. Arq Bras Oftalmol. 2008;71(6 suppl):96-103.

    Google Scholar 

  12. McLaughlin PJ, Sassani JW, Klocek MS, et al. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)–OGF receptor (OGFr) axis with naltrexone: A review. Brain Res Bull. 2010;81:236-247.

    Google Scholar 

  13. Lu WN, Ebihara N, Miyazaki K, et al. Reduced expression of laminin-5 in corneal epithelial cells under high glucose condition. Cornea. 2006;25:61-67.

    Google Scholar 

  14. Fuerst N, Langelier N, Massaro-Giordano M. Tear osmolarity and dry eye symptoms in diabetics. Clin Ophthalmol. 2014;8:507-515.

    Google Scholar 

  15. Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol. 2000;84:19-21.

    Google Scholar 

  16. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulindependent diabetes mellitus. Ophthalmology. 2001;108:586-592.

    Google Scholar 

  17. Ramaesh K, Stokes J, Henry E, Dutton GN, Dhillon B. Congenital corneal anesthesia. Surv Ophthalmol. 2007;52:50-60.

    Google Scholar 

  18. Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571-579.

    Google Scholar 

  19. Wirth M, Nepp J. Korneale sensibilitat bei trockenem auge – eine longitudinale pilotstudie. Spektrum der Augenheilkunde. 2014;28:3.

    Google Scholar 

  20. Norn MS. Measurement of sensitivity. In: Norn MS, ed. External Eye Diseases. Methods of Examination. Copenhagen, Denmark: Munksgaard International Publisher Ltd; 1974.

    Google Scholar 

  21. Belmonte C, Acosta MC, Schmelz M, et al. Measurement of corneal sensitivity to mechanical and chemical stimulation with a CO2 esthesiometer. Invest Ophthalmol Vis Sci. 1999;40:513-519.

    Google Scholar 

  22. Rosenberg ME, Tervo TM, Immonen IJ, et al. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 2000;41:2915-2921.

    Google Scholar 

  23. Cruzat A, Pavan-Langston D, Hamrah P. In vivo confocal microscopy of corneal nerves: analysis and clinical correlation. Semin Ophthalmol. 2010;25:171-177.

    Google Scholar 

  24. Akpek EK, Smith RA. Current treatment strategies for age-related ocular conditions. Am J Manag Care. 2013;19(5 suppl):S76-S84.

    Google Scholar 

  25. Jeng BH, Dupps WJ Jr. Autologous serum 50 % eye drops in the treatment of persistent corneal epithelial defects. Cornea. 2009;28:1104-1108.

    Google Scholar 

  26. Jones D, Tseng S, Pflugfelder S. Atlas of Ophthalmology. Volume 1, Chapter 18. London: Current Medicine; 2012.

    Google Scholar 

  27. Khokhar S, Natung T, Sony P, et al. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea. 2005;24:654-660.

    Google Scholar 

  28. Kruse FE, Rohrschneider K, Volcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology. 1999;106:1504-1510.

    Google Scholar 

  29. Mackie IA. Neuroparalytic keratitis. In: Fraunfelder F, Roy FH, Meyer SM, eds. Current Ocular Therapy. Philadelphia, PA, USA: WB Saunders;1995.

    Google Scholar 

  30. Yamada N, Matsuda R, Morishige N, et al. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy. Br J Ophthalmol. 2008;92:896-900.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

    Viral Juthani

  2. Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, OH, USA

    William J. Dupps

Authors
  1. Viral Juthani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William J. Dupps
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cole Eye Institute,Cleveland Clinic,Case Western Reserve University, Cleveland, Ohio, USA

    Rishi P Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Juthani, V., Dupps, W.J. (2015). Ocular surface disease in diabetes. In: Singh, R. (eds) Managing Diabetic Eye Disease in Clinical Practice. Adis, Cham. https://doi.org/10.1007/978-3-319-08329-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-08329-2_7

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-08328-5

  • Online ISBN: 978-3-319-08329-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation